Viva Biotech Announced 2020 Annual Results
The Group’s Revenue Surged by 115.7% YoY Revenue from the CFS Business Increased Significantly by 146.3% YoY Establish One-stop Service Platform for Novel Drug Discovery and Production via Internal Growth…
Cheney Mao – Chairman & CEO, Viva Biotech, China
Dr Cheney Mao, chairman and CEO of Viva Biotech, shares the extremely unique business model of the company, which started as a highly specialized CRO in 2008, before launching a…
Viva Biotech Announces Proposed Listing on the Main Board of SEHK
Aiming to Become a Cradle for Promising Biotechnology Startups around the World With World-leading Technologies and Scalable Business Model; Offer price between HK$3.42 and HK$4.41 per share HONG KONG –…